Article
Angiotensin-Converting Enzyme 1 (ACE1) gene polymorphisms in pediatric patients with COVID-19: impact on disease severity and outcomes.
BMC medical genomics - 8 Jun 2026
Mahmoudi Shima, Hosseinpour Sadeghi Reihaneh, Pourakbari Babak, Teymuri Mostafa, Mamishi Setareh
Abstract excerpt
BACKGROUND: Angiotensin-converting enzyme 1 (ACE1) gene polymorphisms have been suggested to influence susceptibility to and severity of coronavirus disease 2019 (COVID-19) through dysregulation of the renin-angiotensin system. Despite considerable research on COVID-19, the influence of genetic factors, particularly polymorphisms in the ACE gene, on disease severity in pediatric populations remains inadequately...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
